生物材料驱动的菌体治疗创新:当前的策略和未来的前景
Zihe Zhou1, Mengzhe Li2, Hanyu Fu3
1Department of Laboratory Medicine, Peking University Third Hospital, Beijing, China.
Microbiological research
|September 30, 2025
概括
生物材料通过克服诸如狭窄的宿主范围和细胞内感染等局限性来增强菌体疗法. 这些策略提高了对抗抗菌素耐药性的治疗疗效.
科学领域:
- 生物技术是生物技术.
- 微生物学 微生物学
- 材料科学 材料科学 材料科学
背景情况:
- 抗菌素耐药性 (AMR) 是一个日益增长的全球健康威胁.
- 菌体疗法正在重新出现,成为抗生素有前途的替代品.
- 目前的菌体疗法面临的挑战包括宿主范围,稳定性和细胞内疗效.
研究的目的:
- 审查生物材料辅助菌体治疗的最新进展.
- 突出克服菌体治疗局限性的策略.
- 通过增强的菌体治疗来讨论对抗AMR的未来方向.
主要方法:
- 关于生物材料辅助菌体治疗策略的文献综述.
- 专注于物理封装 (脂质体,水凝) 和表面化学合 (光敏剂,纳米酶).
- 讨论细胞内细菌的菌体可访问性和生物材料选择标准.
主要成果:
- 生物材料提供了改善的菌体输送,稳定性和有针对性的作用.
- 封装和表面修饰策略可以提高治疗效果.
- 细胞内传递和多功能方法是发展的关键领域.
结论:
- 生物材料辅助的菌体治疗提供了一种有效的策略来对抗AMR.
- 生物材料选择的关键考虑因素包括生物安全性,生物降解性和适应性.
- 在治疗精度和多维方法方面的进一步创新至关重要.
相关概念视频
Microorganisms in Medicine and Therapeutics
982
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
982
Lytic Cycle of Bacteriophages
77.4K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
77.4K
DNA Bacteriophages
819
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
819
Lysogenic Cycle of Bacteriophages
67.3K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
67.3K
Biological Methods for Microbial Control
788
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
788
CRISPR and crRNAs
18.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.7K


